Clinical Trial Update: Efficacy Study of Zinc Supplementation on Anemia, Oxidative Stress and Inflammation in Hemodialysis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating zinc supplementation for anemia, oxidative stress, and inflammation in patients with end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• ZINC (Zinc chloride)

Snippet

Sponsor: Ain Shams University | Conditions: End Stage Renal Disease | Phase 2 | Status: COMPLETED